281 related articles for article (PubMed ID: 10894014)
1. [Validation study of the sentinel lymph node (SLN) method in invasive breast carcinoma. Personal data and review of the literature].
Langer I; Zuber M; Köchli OR; Kocher T; Müller-Brand J; Torhorst J; Harder F
Swiss Surg; 2000; 6(3):128-36. PubMed ID: 10894014
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
3. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
[TBL] [Abstract][Full Text] [Related]
4. 200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up.
Reitsamer R; Peintinger F; Prokop E; Rettenbacher L; Menzel C
Br J Cancer; 2004 Apr; 90(8):1551-4. PubMed ID: 15083184
[TBL] [Abstract][Full Text] [Related]
5. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
6. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
10. [Detection of sentinel lymph node in patients with early stage breast cancer].
Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM
Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435
[TBL] [Abstract][Full Text] [Related]
11. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.
Nwariaku FE; Euhus DM; Beitsch PD; Clifford E; Erdman W; Mathews D; Albores-Saavedra J; Leitch MA; Peters GN
Am J Surg; 1998 Dec; 176(6):529-31. PubMed ID: 9926784
[TBL] [Abstract][Full Text] [Related]
13. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
[TBL] [Abstract][Full Text] [Related]
14. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
Gherghe M; Bordea C; Blidaru A
Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
[TBL] [Abstract][Full Text] [Related]
20. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
